Source: Health Canada shortage reports · Updated Oct 27, 2026
Some Dexamethasone products are in shortage in Canada (1 of 12 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 13, 2026.
A corticosteroid used to reduce inflammation and treat many conditions including allergic and immune disorders.
Products affected
1 / 12
In shortage since
Oct 26, 2026
Est. full return
Nov 13, 2026
Reports on file
35
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
10MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00874582 · since Oct 26, 2026, est. end Nov 13, 2026 · Demand increase for the drug.
DIN 00042560 · ended Nov 17, 2022 · Delay in shipping of the drug.
Resolved
DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
10MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00874582 · ended Oct 30, 2023 · Disruption of the manufacture of the drug.
Resolved
DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
10MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00874582 · ended Aug 7, 2023 · Demand increase for the drug.
Resolved
DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
10MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00874582 · ended May 30, 2023 · Demand increase for the drug.
Resolved
DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
10MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00874582 · ended May 1, 2023 · Disruption of the manufacture of the drug.
Resolved
PMS DEXAMETHASONE TAB 0.5MG USP
0.5MG · TABLET · PHARMASCIENCE INC
DIN 01964976 · ended Apr 6, 2023 · Disruption of the manufacture of the drug.
Resolved
DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
10MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00874582 · ended Jan 18, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 35 reports. All reports are on file with Health Canada.
What's happening
Dexamethasone is currently affected by an active shortage report filed with Health Canada by SANDOZ CANADA INCORPORATED.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Dexamethasone is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BA).
Recent changes
Oct 27, 2026
Status changed
Oct 26, 2026
New report filed
Common questions
What is Dexamethasone used for?
A corticosteroid used to reduce inflammation and treat many conditions including allergic and immune disorders.
When will Dexamethasone be back in stock in Canada?
The latest manufacturer estimate is Nov 13, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Dexamethasone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.